Header Logo

Connection

Glen Weiss to Clinical Trials, Phase II as Topic

Back to Details
This is a "connection" page, showing publications Glen Weiss has written about Clinical Trials, Phase II as Topic.
Glen Weiss
Connection Strength
0.101
Clinical Trials, Phase II as Topic
  1. Caldwell S, Sima C, Jameson G, Fleck S, Weiss GJ. Factors influencing time to determination of the recommended phase 2 dose in phase 1 clinical trials. Am J Clin Oncol. 2013 Apr; 36(2):146-50.
    View in: PubMed
    Score: 0.101
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.